AAAAAA
Results: 1-25/38
Authors:
JOHNSON HJ
SWAN SK
HEIMDUTHOY KL
NICHOLLS AJ
TSINA I
TARNOWSKI T
Citation: Hj. Johnson et al., THE PHARMACOKINETICS OF A SINGLE ORAL DOSE OF MYCOPHENOLATE MOFETIL IN PATIENTS WITH VARYING DEGREES OF RENAL-FUNCTION, Clinical pharmacology and therapeutics, 63(5), 1998, pp. 512-518
Authors:
LAMBRECHT LJ
DAVIES BE
MCCLOUD S
PARKER JR
SWAN SK
Citation: Lj. Lambrecht et al., SAFETY AND PHARMACOKINETICS OF GADOBENATE DIMEGLUMINE (GD) IN SUBJECTS WITH RENAL IMPAIRMENT, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 91-91
Authors:
PETERSON PK
LAMBRECHT LJ
SWAN SK
Citation: Pk. Peterson et al., TREATMENT FOR CHRONIC-FATIGUE-SYNDROME - REPLY, Archives of internal medicine, 158(20), 1998, pp. 2266-2267
Authors:
SWAN SK
LAMBRECHT L
ANJUM S
MACRES M
MATHUR VS
FELLMANN J
LUTHER RR
EPSTEIN M
Citation: Sk. Swan et al., RENAL EFFECTS OF FENOLDOPAM (F), A NOVEL PARENTERAL ANTIHYPERTENSIVE,IN NORMOTENSIVE SUBJECTS, Journal of the American Society of Nephrology, 8, 1997, pp. 1485-1485
Authors:
LEWIS MJ
SWAN SK
Citation: Mj. Lewis et Sk. Swan, A POTPOURRI OF DRUG IDIOSYNCRASIES IN ESRD, Seminars in dialysis, 10(5), 1997, pp. 278-281
Authors:
GOERDT PJ
HEIMDUTHOY KL
MACRES M
SWAN SK
Citation: Pj. Goerdt et al., PREDICTIVE PERFORMANCE OF RENAL-FUNCTION ESTIMATE EQUATIONS IN RENAL-ALLOGRAFTS, British journal of clinical pharmacology, 44(3), 1997, pp. 261-265
Authors:
SWAN SK
Citation: Sk. Swan, AMINOGLYCOSIDE NEPHROTOXICITY, Seminars in nephrology, 17(1), 1997, pp. 27-33
Authors:
SWAN SK
LAMBRECHT LJ
STPETER JV
MACRES M
SCHWARZ R
HURSTING M
Citation: Sk. Swan et al., PHARMACOLOGICAL PROFILE OF ARGATROBAN (ARG), A THROMBIN INHIBITOR, INHUMANS WITH IMPAIRED RENAL-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 85-85
Authors:
LAMBRECHT LJ
SWAN SK
CUTLER DL
AFFRIME MB
RADWANSKI E
BATRA V
MACRES M
Citation: Lj. Lambrecht et al., DISPOSITION OF RECOMBINANT HUMAN INTERLEUKIN-10 (IL-10) IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 87-87
Authors:
COSGROVE JD
STPETER JV
SWAN SK
LAMBRECHT LJ
Citation: Jd. Cosgrove et al., COMPARISON OF RECRUITING STRATEGIES FOR ENROLLMENT OF RENALLY IMPAIRED SUBJECTS IN CLINICAL-TRIALS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 93-93
Authors:
SWAN SK
Citation: Sk. Swan, THE SEARCH CONTINUES - AN IDEAL MARKER OF GFR, Clinical chemistry, 43(6), 1997, pp. 913-914
Authors:
BREEN GA
STPETER JV
MACRES M
SWAN SK
Citation: Ga. Breen et al., PREDICTING CREATININE CLEARANCE (CLCR) IN DIABETIC (DM) AND RENAL-TRANSPLANT (TX) PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 683-683
Authors:
SWAN SK
LAMBRECHT LJ
STPETER JV
MACRES M
SCHWARZ R
Citation: Sk. Swan et al., PHARMACOLOGICAL PROFILE OF ARGATROBAN, A THROMBIN INHIBITOR, IN HUMANS WITH IMPAIRED RENAL-FUNCTION, Journal of the American Society of Nephrology, 7(9), 1996, pp. 769-769
Authors:
SWAN SK
LAMBRECHT LJ
VARGASRUIZ M
HILLEGAS M
BUSHMAN L
Citation: Sk. Swan et al., IOHEXOL STABILITY IN POLYPROPYLENE SYRINGES, Journal of the American Society of Nephrology, 7(9), 1996, pp. 770-770
Authors:
RAGURAM PC
CRARY GS
SWAN SK
KASISKE BL
KIM Y
GRANTHAM JJ
KEANE WF
ODONNELL MP
Citation: Pc. Raguram et al., LOCALIZATION OF RAS IN CYSTIC EPITHELIAL-CELLS IN HUMAN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD), Journal of the American Society of Nephrology, 7(9), 1996, pp. 1862-1862
Authors:
VARGO DL
BRATER DC
RUDY DW
SWAN SK
Citation: Dl. Vargo et al., DOPAMINE DOES NOT ENHANCE FUROSEMIDE-INDUCED NATRIURESIS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Journal of the American Society of Nephrology, 7(7), 1996, pp. 1032-1037
Authors:
SWAN SK
HALSTENSON CE
KASISKE BL
COLLINS AJ
Citation: Sk. Swan et al., DETERMINATION OF RESIDUAL RENAL-FUNCTION WITH IOHEXOL CLEARANCE IN HEMODIALYSIS-PATIENTS, Kidney international, 49(1), 1996, pp. 232-235
Authors:
SAVIN VJ
SHARMA R
SHARMA M
MCCARTHY ET
SWAN SK
ELLIS E
LOVELL H
WARADY B
GUNWAR S
CHONKO AM
ARTERO M
VINCENTI F
FINE R
WOOD E
TRACHTMAN H
Citation: Vj. Savin et al., CIRCULATING FACTOR ASSOCIATED WITH INCREASED GLOMERULAR-PERMEABILITY TO ALBUMIN IN RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS, The New England journal of medicine, 334(14), 1996, pp. 878-883
Authors:
KRAEMER MD
HENRY TD
SWAN SK
HERZOG CA
Citation: Md. Kraemer et al., INCREASED PREVALENCE OF CORONARY-ARTERY ANEURYSMS IN POLYCYSTIC KIDNEY-DISEASE, Circulation, 94(8), 1996, pp. 548-548
Authors:
HURSTING MJ
JOFFRION JL
BROOKS RL
SWAN SK
Citation: Mj. Hursting et al., THE SAFETY AND EFFICACY OF ARGATROBAN (A DIRECT THROMBIN INHIBITOR) AT DOSES PRODUCING ACTIVATING CLOTTING TIMES OF GREATER-THAN-OR-EQUAL-TO-300 SECONDS IN HEALTHY-VOLUNTEERS, Blood, 88(10), 1996, pp. 3056-3056
Authors:
HURSTING MJ
JOFFRION JL
BROOKS RL
SWAN SK
Citation: Mj. Hursting et al., A COMPARISON OF THE PHARMACODYNAMICS OF HEPARIN AND ARGATROBAN (A DIRECT THROMBIN INHIBITOR) IN HEALTHY-VOLUNTEERS, Blood, 88(10), 1996, pp. 657-657
Authors:
HURSTLING MJ
JOFFRION JL
BROOKS RL
SWAN SK
SARRIS AH
Citation: Mj. Hurstling et al., EFFECT OF RENAL-FUNCTION ON THE PHARMACOKINETICS AND PHARMACODYNAMICSOF ARGATROBAN (A DIRECT THROMBIN INHIBITOR), Blood, 88(10), 1996, pp. 658-658
Authors:
CRARY GS
SWAN SK
ODONNELL MP
KASISKE BL
KATZ SA
KEANE WF
Citation: Gs. Crary et al., THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN REDUCES BLOOD-PRESSURE BUT NOT RENAL INJURY IN OBESE ZUCKER RATS, Journal of the American Society of Nephrology, 6(4), 1995, pp. 1295-1299
Authors:
SWAN SK
VARGO DL
RUDY DL
BRATER DC
Citation: Sk. Swan et al., DOPAMINE (DA) DOES NOT ENHANCE FUROSEMIDE (F)-INDUCED NATRIURESIS IN PATIENTS WITH COMPENSATED CONGESTIVE-HEART-FAILURE (CHF), Journal of the American Society of Nephrology, 6(3), 1995, pp. 477-477
Authors:
SWAN SK
HALSTENSON CE
COLLINS AJ
COLBURN WA
BLUE J
PRZYBELSKI RJ
Citation: Sk. Swan et al., PHARMACOLOGICAL PROFILE OF DIASPIRIN CROSS-LINKED HEMOGLOBIN IN HEMODIALYSIS-PATIENTS, American journal of kidney diseases, 26(6), 1995, pp. 918-923